Abbott

Navitor Vision enhances visibility and precision in TAVI procedures, offering a less invasive alternative to surgical aortic valve…

Gavin Cloherty, Head-infectious disease research, Abbott and Head, Abbott Pandemic Defense Coalition in an interview with Kavita…

The single-chamber ventricular leadless pacemaker is made for the treatment of patients in India with slow heart rhythms

Transcatheter tricuspid valve repair sees swift market growth as Abbott’s Triclip captures majority share

Event explored behavioural insights and tech innovations for improving treatment adherence

Survey reveals that infectious disease experts see the need to address gaps in surveillance programs to identify emerging…

Medtronic's new collaboration with Abbott aims to enhance its diabetes care offerings by integrating advanced glucose monitoring…

Abbott's AVEIR DR dual chamber leadless pacemaker disrupts the market, capturing significant share from Medtronic and setting new…

The Blue Shed facility in Delhi will offer holistic care to people who are vulnerable to HIV, hepatitis, and other infectious…

The global dual chamber leadless pacemaker market is poised to grow at a CAGR of 8.95 per cent from $185.9 million in 2023 to $438…